So Yoon Sim

1.0k total citations
20 papers, 319 citations indexed

About

So Yoon Sim is a scholar working on Health, Infectious Diseases and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, So Yoon Sim has authored 20 papers receiving a total of 319 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Health, 9 papers in Infectious Diseases and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in So Yoon Sim's work include Vaccine Coverage and Hesitancy (18 papers), Global Maternal and Child Health (7 papers) and Viral gastroenteritis research and epidemiology (5 papers). So Yoon Sim is often cited by papers focused on Vaccine Coverage and Hesitancy (18 papers), Global Maternal and Child Health (7 papers) and Viral gastroenteritis research and epidemiology (5 papers). So Yoon Sim collaborates with scholars based in Switzerland, United States and United Kingdom. So Yoon Sim's co-authors include Dagna Constenla, Logan Brenzel, Bryan Patenaude, Raymond Hutubessy, Elizabeth Watts, Ann Lindstrand, Austin Carter, Katy A. M. Gaythorpe, William Msemburi and Mark Jit and has published in prestigious journals such as PLoS Medicine, American Journal of Preventive Medicine and Health Affairs.

In The Last Decade

So Yoon Sim

16 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
So Yoon Sim Switzerland 10 206 150 99 51 49 20 319
Saheed Gidado Nigeria 11 172 0.8× 140 0.9× 143 1.4× 53 1.0× 58 1.2× 39 341
Ndadilnasiya Endie Waziri Nigeria 12 185 0.9× 183 1.2× 167 1.7× 74 1.5× 59 1.2× 34 390
Élise Guillermet France 8 220 1.1× 103 0.7× 110 1.1× 61 1.2× 43 0.9× 20 307
Pascal Mkanda Republic of the Congo 14 173 0.8× 321 2.1× 118 1.2× 75 1.5× 53 1.1× 31 540
Simrun Grewal United States 7 222 1.1× 119 0.8× 86 0.9× 45 0.9× 88 1.8× 12 361
Artur Manuel Muloliwa Mozambique 12 213 1.0× 104 0.7× 118 1.2× 33 0.6× 82 1.7× 19 350
Samantha Clark United States 8 304 1.5× 145 1.0× 204 2.1× 66 1.3× 89 1.8× 19 485
Meghan L. Stack United States 7 318 1.5× 152 1.0× 128 1.3× 74 1.5× 100 2.0× 9 486
Richard Banda Nigeria 15 167 0.8× 234 1.6× 138 1.4× 85 1.7× 76 1.6× 39 523
Emmanuel Abanida Nigeria 11 181 0.9× 280 1.9× 138 1.4× 64 1.3× 38 0.8× 17 498

Countries citing papers authored by So Yoon Sim

Since Specialization
Citations

This map shows the geographic impact of So Yoon Sim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by So Yoon Sim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites So Yoon Sim more than expected).

Fields of papers citing papers by So Yoon Sim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by So Yoon Sim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by So Yoon Sim. The network helps show where So Yoon Sim may publish in the future.

Co-authorship network of co-authors of So Yoon Sim

This figure shows the co-authorship network connecting the top 25 collaborators of So Yoon Sim. A scholar is included among the top collaborators of So Yoon Sim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with So Yoon Sim. So Yoon Sim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oliwa, Jacquie, Fatuma Guleid, Jacinta Nzinga, et al.. (2025). Framework to guide the use of mathematical modelling in evidence-based policy decision-making. BMJ Open. 15(4). e093645–e093645. 1 indexed citations
2.
Leask, Julie, Ikram Abdi, Franck Mboussou, et al.. (2025). Informing the development of transmission modelling guidance for global immunization decision-making: A qualitative needs assessment. Vaccine. 49. 126800–126800.
3.
Trotter, Caroline, Birgitte Giersing, Ann Lindstrand, et al.. (2024). A Practical Guide to Full Value of Vaccine Assessments. Vaccines. 12(2). 201–201. 5 indexed citations
4.
Thakkar, Niket, Philipp Lambach, So Yoon Sim, et al.. (2024). Estimating the Impact of Vaccination Campaigns on Measles Transmission in Somalia. Vaccines. 12(3). 314–314. 4 indexed citations
5.
Guleid, Fatuma, Vincent Were, So Yoon Sim, et al.. (2024). Lessons learned from COVID-19 modelling efforts for policy decision-making in lower- and middle-income countries. BMJ Global Health. 9(11). e015247–e015247. 6 indexed citations
6.
Portnoy, Allison, Rebecca A. Clark, Matthew Quaife, et al.. (2023). The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study. PLoS Medicine. 20(1). e1004155–e1004155. 22 indexed citations
7.
Carter, Austin, William Msemburi, So Yoon Sim, et al.. (2023). Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030. Vaccine. 42. S28–S37. 57 indexed citations
8.
Sim, So Yoon, et al.. (2023). Financing And Funding Gap For 16 Vaccines Across 94 Low- And Middle-Income Countries, 2011–30. Health Affairs. 42(1). 94–104. 5 indexed citations
9.
Hutubessy, Raymond, Jeremy A. Lauer, Birgitte Giersing, et al.. (2023). The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making. BMC Medicine. 21(1). 229–229. 36 indexed citations
12.
Hutubessy, Raymond, Jeremy A. Lauer, Birgitte Giersing, et al.. (2021). The Full Value of Vaccine Assessments (FVVA): A Framework to Assess and Communicate the Value of Vaccines for Investment and Introduction Decision Making. SSRN Electronic Journal. 16 indexed citations
13.
Carter, Austin, William Msemburi, So Yoon Sim, et al.. (2021). Modeling the Impact of Vaccination for the Immunization Agenda 2030: Deaths Averted Due to Vaccination Against 14 Pathogens in 194 Countries from 2021-2030. SSRN Electronic Journal. 25 indexed citations
15.
Sim, So Yoon, et al.. (2020). Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030. Value in Health. 24(1). 70–77. 18 indexed citations
17.
Sim, So Yoon, et al.. (2020). Cost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness Studies. PharmacoEconomics. 38(10). 1071–1094. 13 indexed citations
18.
Bartsch, Sarah M., Lindsey Asti, So Yoon Sim, et al.. (2020). The Potential Economic Value of a Zika Vaccine for a Woman of Childbearing Age. American Journal of Preventive Medicine. 58(3). 370–377. 1 indexed citations
19.
Sim, So Yoon, Elizabeth Watts, Dagna Constenla, Logan Brenzel, & Bryan Patenaude. (2020). Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30. Health Affairs. 39(8). 1343–1353. 76 indexed citations
20.
Sim, So Yoon, Mark Jit, Dagna Constenla, David H. Peters, & Raymond Hutubessy. (2019). A Scoping Review of Investment Cases for Vaccines and Immunization Programs. Value in Health. 22(8). 942–952. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026